GT Therapeutics, the targeted acquisition firm of Winston Resources Inc (CNSX:WRW), has presented two new vaporizers into the expanding Cannabis industry. With the presentation of these two products in market for sale, the firm has expanded its offerings pipeline.
Winston Resources announced that the two vaporizers that are recently introduced are given unique names, the first one being called Slim Vape, and the second as Variable Vape. The first offering, Slim Vape, comes with a mouthpiece having an inbuilt transparent tank. It is here at this place the users can place CBD and THC oil. It is about 140mm x 8mm, which implies it is discrete, light and useful product. The product has an internal battery fit in so as to support easy recharge.
Slim Vape offering of Winston is “Big in function” while Variable Vape is “Built for Power and Durability.” Variable Vape boasts an attached mouth piece as well as an atomizer to carry cannabinoid and THC oils. The product offers the benefit of adjusting the temperature. As some CBD oils exhibit distinct optimal vaporizing temperatures, the company has given features to optimize users experience.
Quinn Field-Dyte, who the CEO of Winston Resources, expressed that the scope in the cannabis world is in ancillary offerings, branding and concentrates. By bringing these two kinds of vale in the market, they are reinforcing their market share and position in the prospective areas. Users look for state-of-the-art custom and functional designs. With the fresh products launched, the company has achieved another step towards closing its mission.
A couple of months ago, Winston and GT finalized a contract, as per which Winston Resources will go for a reverse takeover and get entire stake in Green Tree Therapeutics. On deal completion, Green Tree will become the company’s subsidiary unit, and the firm will own the Pigeon River asset.
Can CBD Oil Get Rid of Chronic Pain?http://www.greenleaf.farm
Pure Colorado Golden CBD Oil Hemp Extracts
2017 Most Disruptive Biotech VBIOhttp://www.financialstrend.com
Disruptive biotech VBIO decodes targeted drug delivery for stem cells
Top Stock Analysis At Journal Transcripthttp://www.journaltranscript.com
Early bird alerts on the hottest OTC companies